Clearmind Medicine Inc. is a biotech company focused on discovering and developing psychedelic derived therapeutics to solve widespread health problems like alcohol use disorder. Their first drug candidate, 5-Methoxy-2-aminoindane (MEAI), offers a safe and promising solution by providing a euphoric alcohol-like experience and reducing the desire to consume alcoholic beverages. With a strong medical management team and protected treatments, Clearmind aims to improve the lives of millions struggling with alcohol-related issues.